Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F MacMillan

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Biochemistry|May 14, 2003
Asymmetric binding of the high-affinity Q(H)(*)(-) ubisemiquinone in quinol oxidase (bo3) from Escherichia coli studied by multifrequency electron paramagnetic resonance spectroscopyS Grimaldi, T Ostermann, N Weiden, et al.
Lancet (London, England)|July 7, 1979
Virus-like particles in CSF in schizophreniaT J Grow, D A Tyrrell, I N Ferrier, et al.
Lancet (London, England)|April 21, 1979
Characteristics of patients with schizophrenia or neurological disorder and virus-like agent in cerebrospinal fluidT J Crow, I N Ferrier, E C Johnstone, et al.
Contemporary Clinical Trials Communications|May 7, 2025
Study protocol: Apps and peer support for a healthy future and living well with diabetes (APHLID-M)K O Mathews, F MacMillan, V Wong, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Biochemistry|May 14, 2003
Asymmetric binding of the high-affinity Q(H)(*)(-) ubisemiquinone in quinol oxidase (bo3) from Escherichia coli studied by multifrequency electron paramagnetic resonance spectroscopyS Grimaldi, T Ostermann, N Weiden, et al.
Lancet (London, England)|July 7, 1979
Virus-like particles in CSF in schizophreniaT J Grow, D A Tyrrell, I N Ferrier, et al.
Lancet (London, England)|April 21, 1979
Characteristics of patients with schizophrenia or neurological disorder and virus-like agent in cerebrospinal fluidT J Crow, I N Ferrier, E C Johnstone, et al.
Contemporary Clinical Trials Communications|May 7, 2025
Study protocol: Apps and peer support for a healthy future and living well with diabetes (APHLID-M)K O Mathews, F MacMillan, V Wong, et al.
Pageof 6